Literature DB >> 7119826

Smoking and Parkinson's disease.

R B Godwin-Austen, P N Lee, M G Marmot, G M Stern.   

Abstract

In a case control study of the relationship between smoking habits and Parkinson's disease a negative association was demonstrated with a relative risk of 0 x 52. A history of smoking up to 20 years earlier was associated with a risk of developing Parkinson's disease equal to about half that in non-smokers. The type of disease, age of onset and rate of progression were associated with a similar reduction in risk implying that in respect of smoking history the disease is homogeneous. The positive correlation of degenerative vascular disease with smoking is further evidence that arteriosclerosis is not involved in the causation of Parkinson's disease. The negative association between Parkinson's disease and smoking is confirmed and is independent of other associated factors. The known and serious risks of smoking far outweigh the possible benefit of lowered risk of Parkinson's disease.

Entities:  

Mesh:

Year:  1982        PMID: 7119826      PMCID: PMC491470          DOI: 10.1136/jnnp.45.7.577

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  6 in total

1.  Epidemiologic studies of Parkinson's disease. 3. A community-based survey.

Authors:  I I Kessler
Journal:  Am J Epidemiol       Date:  1972-10       Impact factor: 4.897

2.  A retrospective study of smoking in Parkinson's disease.

Authors:  M D Nefzger; F A Quadfasel; V C Karl
Journal:  Am J Epidemiol       Date:  1968-09       Impact factor: 4.897

3.  Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: a survey and explanatory hypothesis.

Authors:  I I Kessler; E L Diamond
Journal:  Am J Epidemiol       Date:  1971-07       Impact factor: 4.897

4.  Mortality in relation to smoking: 20 years' observations on male British doctors.

Authors:  R Doll; R Peto
Journal:  Br Med J       Date:  1976-12-25

5.  Cigarette smoking and Parkinson disease: 1. Comparison of cases with matched neighbors.

Authors:  R J Baumann; H D Jameson; H E McKean; D G Haack; L M Weisberg
Journal:  Neurology       Date:  1980-08       Impact factor: 9.910

6.  Smoking and Parkinson's disease.

Authors:  R J Marttila; U K Rinne
Journal:  Acta Neurol Scand       Date:  1980-11       Impact factor: 3.209

  6 in total
  27 in total

1.  Clinical features and associations of 560 cases of motor neuron disease.

Authors:  T M Li; E Alberman; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

2.  Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection.

Authors:  K Fuxe; A M Janson; A Jansson; K Andersson; P Eneroth; L F Agnati
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

Review 3.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

4.  Parkin is transcriptionally regulated by the aryl hydrocarbon receptor: Impact on α-synuclein protein levels.

Authors:  Emmanuel González-Barbosa; Rosario García-Aguilar; Libia Vega; María Asunción Cabañas-Cortés; Frank J Gonzalez; José Segovia; Sara L Morales-Lázaro; Bulmaro Cisneros; Guillermo Elizondo
Journal:  Biochem Pharmacol       Date:  2019-08-09       Impact factor: 5.858

5.  Acute reduction of brain substance P induced by nicotine.

Authors:  N E Naftchi; H Maker; E Lapin; J Sleis; A Lajtha; S Leeman
Journal:  Neurochem Res       Date:  1988-04       Impact factor: 3.996

6.  Cigarette smoking, Parkinson's disease and ulcerative colitis.

Authors:  K Bihari; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

Review 7.  Gene-by-environment interactions in Alzheimer's disease and Parkinson's disease.

Authors:  Amy R Dunn; Kristen M S O'Connell; Catherine C Kaczorowski
Journal:  Neurosci Biobehav Rev       Date:  2019-06-14       Impact factor: 8.989

Review 8.  Hypothesis: a nicotine-dopamine interaction linking smoking with Parkinson's disease and tardive dyskinesia.

Authors:  D G Kirch; A M Alho; R J Wyatt
Journal:  Cell Mol Neurobiol       Date:  1988-09       Impact factor: 5.046

Review 9.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

10.  Smoking and dementia of Alzheimer type.

Authors:  G M Jones; M Reith; M P Philpot; B J Sahakian
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.